Patents by Inventor Keith Jensen
Keith Jensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10806703Abstract: The present invention relates to a transmucosal administration system to administer quinones, benzoquinones, and especially 1,4-benzoquinones, via the oromucosal route.Type: GrantFiled: January 20, 2012Date of Patent: October 20, 2020Assignees: LTS Lohmann Therapie-System AG, Santhera Pharmaceuticals (Schweitz) AGInventors: Markus Krumme, Keith Jensen, Judith Dubach-Powell, Rudolf Hausmann
-
Patent number: 10716762Abstract: The present invention relates to a transmucosal administration system to administer quinones, benzoquinones, and especially 1,4-benzoquinones, via the oromucosal route.Type: GrantFiled: January 17, 2013Date of Patent: July 21, 2020Assignee: LTS Lohmann Therapie-Systeme AGInventors: Markus Krumme, Keith Jensen, Judith Dubach-Powell, Rudolf Hausmann
-
Patent number: 10704260Abstract: An insulated concrete panel comprising an insulation layer having one or more openings extending therethrough, a first concrete layer adjacent to a first surface of the insulation layer, a second concrete layer adjacent to a second surface of the insulation layer, and a wall tie received within one or more of the openings. The wall tie includes a central section received within the one or more openings of the insulation layer, a first concrete engaging at least partially embedded within the first concrete layer, and a second concrete engaging section embedded within the second concrete layer. The second concrete engaging section has a maximum width that is larger than a maximum width of the central section. The central section of the wall tie is configured to transfer shear forces and resist delamination forces between the first and second concrete layers.Type: GrantFiled: December 31, 2018Date of Patent: July 7, 2020Assignee: IconX, LLCInventors: Joel Foderberg, Keith Jensen
-
Publication number: 20190350872Abstract: The invention generally relates to transmucosal administration systems for administering quinones, benzoquinones, and especially 1,4-benzoquinones, via the oromucosal route. The present invention more specifically relates to methods of treatment for Duchenne Muscular Dystrophy that includes administering to a patient a dose in the form of one or more transmucosal administration systems.Type: ApplicationFiled: August 5, 2019Publication date: November 21, 2019Inventors: Markus KRUMME, Keith JENSEN, Judith DUBACH-POWELL, Rudolf HAUSMANN
-
Publication number: 20190136526Abstract: An insulated concrete panel comprising an insulation layer having one or more openings extending therethrough, a first concrete layer adjacent to a first surface of the insulation layer, a second concrete layer adjacent to a second surface of the insulation layer, and a wall tie received within one or more of the openings. The wall tie includes a central section received within the one or more openings of the insulation layer, a first concrete engaging at least partially embedded within the first concrete layer, and a second concrete engaging section embedded within the second concrete layer. The second concrete engaging section has a maximum width that is larger than a maximum width of the central section. The central section of the wall tie is configured to transfer shear forces and resist delamination forces between the first and second concrete layers.Type: ApplicationFiled: December 31, 2018Publication date: May 9, 2019Inventors: Joel Foderberg, Keith Jensen
-
Patent number: 10167633Abstract: An insulated concrete panel comprising an insulation layer having one or more openings extending therethrough, a first concrete layer adjacent to a first surface of the insulation layer, a second concrete layer adjacent to a second surface of the insulation layer, and a wall tie received within one or more of the openings. The wall tie includes a central section received within the one or more openings of the insulation layer, a first concrete engaging at least partially embedded within the first concrete layer, and a second concrete engaging section embedded within the second concrete layer. The second concrete engaging section has a maximum width that is larger than a maximum width of the central section. The central section of the wall tie is configured to transfer shear forces and resist delamination forces between the first and second concrete layers.Type: GrantFiled: November 14, 2016Date of Patent: January 1, 2019Assignee: IconX, LLCInventors: Joel Foderberg, Keith Jensen
-
Patent number: 10132080Abstract: A concrete tie for use in an insulated concrete panel, the concrete tie including a main body having (1) a length, an inner surface, and an outer surface; (2) a protrusion extending away from the inner surface of the main body and along the length thereof; (3) at least one upper foot extending above a top surface of the main body and at least one lower foot extending below a bottom surface of the main body, wherein the protrusion is configured to engage with a slot formed in an insulation layer.Type: GrantFiled: February 21, 2017Date of Patent: November 20, 2018Inventor: Keith Jensen
-
Publication number: 20180238053Abstract: A concrete tie for use in an insulated concrete panel, the concrete tie including a main body having (1) a length, an inner surface, and an outer surface; (2) a protrusion extending away from the inner surface of the main body and along the length thereof; (3) at least one upper foot extending above a top surface of the main body and at least one lower foot extending below a bottom surface of the main body, wherein the protrusion is configured to engage with a slot formed in an insulation layer.Type: ApplicationFiled: February 21, 2017Publication date: August 23, 2018Inventor: Keith Jensen
-
Publication number: 20170348321Abstract: The invention relates to a pharmaceutical composition in the form of a system in film form for transmucosal administration of steroid hormones. An administration system for steroid hormones which dissolves in the mouth and which releases with a high bioavailability is disclosed. The administration system in film form dissolves in the mouth preferably in a period of less than 30 min, and the steroid hormone entering the bloodstream transmucosally from the administration system leads to a rapid rise in the concentration in the blood. It is thus possible to achieve a maximum concentration of this steroid hormone in the blood in a period of less than 60 min after administration.Type: ApplicationFiled: August 23, 2017Publication date: December 7, 2017Applicant: LTS Lohmann Therapie-Systeme AGInventors: Markus Krumme, Albert Radlmaier, Sescha General, Michael Dittgen, Keith Jensen
-
Patent number: 9763960Abstract: The invention relates to a pharmaceutical composition in the form of a system in film form for transmucosal administration of steroid hormones. An administration system for steroid hormones which dissolves in the mouth and which releases with a high bioavailability is disclosed. The administration system in film form dissolves in the mouth preferably in a period of less than 30 min, and the steroid hormone entering the bloodstream transmucosally from the administration system leads to a rapid rise in the concentration in the blood. It is thus possible to achieve a maximum concentration of this steroid hormone in the blood in a period of less than 60 min after administration.Type: GrantFiled: March 28, 2006Date of Patent: September 19, 2017Assignee: LTS Lohmann Theraple-Systeme AGInventors: Markus Krumme, Albert Radlmaier, Sascha General, Michael Dittgen, Keith Jensen
-
Patent number: 9758462Abstract: A process utilizing nitric acid and oxygen as co-oxidants to oxidize aldehydes, alcohols, polyols, preferably carbohydrates, specifically reducing sugars to produce the corresponding carboxylic acids.Type: GrantFiled: October 20, 2015Date of Patent: September 12, 2017Assignee: RIVERTOP RENEWABLES, INC.Inventors: Steven Donen, Kirk Hash, Tyler Smith, Keith Jensen
-
Patent number: 9670124Abstract: A process utilizing nitric acid and oxygen as co-oxidants to oxidize aldehydes, alcohols, polyols, preferably carbohydrates, specifically reducing sugars to produce the corresponding carboxylic acids.Type: GrantFiled: March 12, 2014Date of Patent: June 6, 2017Assignee: RIVERTOP RENEWABLES, INC.Inventors: Steven Donen, Keith Jensen
-
Publication number: 20170058519Abstract: An insulated concrete panel comprising an insulation layer having one or more openings extending therethrough, a first concrete layer adjacent to a first surface of the insulation layer, a second concrete layer adjacent to a second surface of the insulation layer, and a wall tie received within one or more of the openings. The wall tie includes a central section received within the one or more openings of the insulation layer, a first concrete engaging at least partially embedded within the first concrete layer, and a second concrete engaging section embedded within the second concrete layer. The second concrete engaging section has a maximum width that is larger than a maximum width of the central section. The central section of the wall tie is configured to transfer shear forces and resist delamination forces between the first and second concrete layers.Type: ApplicationFiled: November 14, 2016Publication date: March 2, 2017Inventors: Joel Foderberg, Keith Jensen
-
Patent number: 9493946Abstract: An insulated concrete panel comprising an insulation layer having one or more openings extending therethrough, a first concrete layer adjacent to a first surface of the insulation layer, a second concrete layer adjacent to a second surface of the insulation layer, and a wall tie received within one or more of the openings. The wall tie includes a central section received within the one or more openings of the insulation layer, a first concrete engaging at least partially embedded within the first concrete layer, and a second concrete engaging section embedded within the second concrete layer. The second concrete engaging section has a maximum width that is larger than a maximum width of the central section. The central section of the wall tie is configured to transfer shear forces and resist delamination forces between the first and second concrete layers.Type: GrantFiled: March 13, 2015Date of Patent: November 15, 2016Assignee: IconX, LLCInventors: Joel Foderberg, Keith Jensen
-
Publication number: 20160039735Abstract: A process utilizing nitric acid and oxygen as co-oxidants to oxidize aldehydes, alcohols, polyols, preferably carbohydrates, specifically reducing sugars to produce the corresponding carboxylic acids.Type: ApplicationFiled: October 20, 2015Publication date: February 11, 2016Inventors: Steven Donen, Kirk Hash, Tyler Smith, Keith Jensen
-
Patent number: 9187398Abstract: A process utilizing nitric acid and oxygen as co-oxidants to oxidize aldehydes, alcohols, polyols, preferably carbohydrates, specifically reducing sugars to produce the corresponding carboxylic acids.Type: GrantFiled: March 12, 2014Date of Patent: November 17, 2015Assignee: Rivertop Renewables, Inc.Inventors: Steven Donen, Kirk Hash, Tyler Smith, Keith Jensen
-
Publication number: 20150184383Abstract: An insulated concrete panel comprising an insulation layer having one or more openings extending therethrough, a first concrete layer adjacent to a first surface of the insulation layer, a second concrete layer adjacent to a second surface of the insulation layer, and a wall tie received within one or more of the openings. The wall tie includes a central section received within the one or more openings of the insulation layer, a first concrete engaging at least partially embedded within the first concrete layer, and a second concrete engaging section embedded within the second concrete layer. The second concrete engaging section has a maximum width that is larger than a maximum width of the central section. The central section of the wall tie is configured to transfer shear forces and resist delamination forces between the first and second concrete layers.Type: ApplicationFiled: March 13, 2015Publication date: July 2, 2015Inventors: Joel Foderberg, Keith Jensen
-
Publication number: 20140377312Abstract: The present invention relates to a transmucosal administration system to administer quinones, benzoquinones, and especially 1,4-benzoquinones, via the oromucosal route.Type: ApplicationFiled: January 17, 2013Publication date: December 25, 2014Applicant: Santhera Pharmaceuticals (Schweitz) AGInventors: Markus Krumme, Keith Jensen, Judith Dubach-Powell, Rudolf Hausmann
-
Publication number: 20140275623Abstract: A process utilizing nitric acid and oxygen as co-oxidants to oxidize aldehydes, alcohols, polyols, preferably carbohydrates, specifically reducing sugars to produce the corresponding carboxylic acids.Type: ApplicationFiled: March 12, 2014Publication date: September 18, 2014Inventors: Steven Donen, Kirk Hash, Tyler Smith, Keith Jensen
-
Publication number: 20140275622Abstract: A process utilizing nitric acid and oxygen as co-oxidants to oxidize aldehydes, alcohols, polyols, preferably carbohydrates, specifically reducing sugars to produce the corresponding carboxylic acids.Type: ApplicationFiled: March 12, 2014Publication date: September 18, 2014Inventors: Steven Donen, Keith Jensen